Verity Asset Management, Inc. Shockwave Medical, Inc. Transaction History

Verity Asset Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 28, 2024	SELL	$191.17 - $325.63 $49,704 - $84,663	-260 Reduced 4.99%	4,948 $1.61 Billion
Q4 2023 Feb 08, 2024	BUY	$160.99 - $215.69 $124,445 - $166,728	773 Added 17.43%	5,208 $992 Million
Q3 2023 Nov 22, 2023	BUY	$194.33 - $283.97 $41,586 - $60,769	214 Added 5.07%	4,435 $883 Million
Q2 2023 Aug 15, 2023	SELL	$223.05 - $302.68 $131,599 - $178,581	-590 Reduced 12.26%	4,221 $1.2 Billion
Q1 2023 May 24, 2023	BUY	$175.41 - $217.92 $57,534 - $71,477	328 Added 7.32%	4,811 $1.04 Billion
Q4 2022 Feb 14, 2023	BUY	$204.38 - $296.82 $710,833 - $1.03 Million	3,478 Added 346.07%	4,483 $922 Million
Q3 2022 Nov 15, 2022	BUY	$195.21 - $310.53 $196,186 - $312,082	1,005 New	1,005 $279 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Verity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Verity Asset Management, Inc. with notifications on news.